MAPK3 and urinary bladder carcinoma: In parallel, a similar analysis was performed for the expression levels of therespective central genes of these pathways: MAPK3 andMAPK1 (Fig. 3).For the individual gene level, only for bladder carcinoma did both genes showa consistent trend (were negative biomarkers) for both OS and PFS data.